We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Pgn6.0
Panax Ginseng Research
Likely helps
239 peer-reviewed studies
What the evidence says
Likely helps
Panax Ginseng appears to help in 9 of 9 studies with measurable effects — the evidence leans clearly favourable.
Most evidence is from high-quality meta-analyses and randomised trials published 1990–2026 with a typical study size of 180 participants.
Based on 239 studies · 34 meta-analyses · 140 RCTs · 12,621 total participants
Confidence
High confidence
What the studies found
9helped· 230 more without graded effect data
By outcome
Energy & fatigueReduced fatigue and improved vitality · 2-4 weeks
Likely helps162 studies
Therapeutic & clinical
Likely helps39 studies
Cognitive functionGinsenosides enhance cognitive function and working memory · 4-8 weeks
Mostly mechanism / observational22 studies
Glucose & metabolic
Mostly mechanism / observational19 studies
Women's health
Mostly mechanism / observational13 studies
Heart & blood pressure
Mostly mechanism / observational12 studies
Men's vitalityErectile function and libido support · 4-8 weeks
Mostly mechanism / observational9 studies
Endurance & exercise performanceAdaptogenic support improves exercise capacity and VO2max · 4-8 weeks · Modest improvements in endurance and fatigue resistance · 4-8 weeks
Immune supportImmunomodulatory ginsenosides enhance NK cell activity · 4-8 weeks
Mostly mechanism / observational3 studies
Cholesterol & lipids
Mostly mechanism / observational3 studies
Fertility & reproductive
Mostly mechanism / observational3 studies
Weight management
Mostly mechanism / observational3 studies
Inflammation
Too few graded studies1 study
By the numbers
Pulled from 35 studies with measurable effects
Likely real effects
100%
across studies
People studied
13k
typical study: 180 people
Strongest designs
174
34 pooled, 140 randomised
Showed benefit
100%
9/9 studies
How long studies ran
1–4 weeks
2
3+ months
1
Populations Studied
Healthy adults2
Women with female sexual dysfunction1
Stable COPD patients1
Colorectal cancer patients receiving oxaliplatin-based chemotherapy1
Active research area
92 studies in the last 5 years · Latest meta-analysis: 2025
199020082026
1Sexual arousalMeta-Analysisn=536 · large study2021
In plain English: Preliminary evidence suggests that Tribulus terrestris and Panax ginseng may be effective as alternative treatments for FSD in a clinical setting.
Sha'ari N et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology (2021)
Large benefit
← WorseNo effectBetter →
Likely real
Panax ginseng was found to be effective in treating sexual arousal (SMD = 0.54, 95% CI = 0.11 - 0.97, p = 0.014) and sexual desire (SMD = 0.59, 95% CI = 0.27 - 0.90, p < 0.001) compared to placebo.
Preliminary evidence suggests that Tribulus terrestris and Panax ginseng may be effective as alternative treatments for FSD in a clinical setting.
2BODE indexSystematic Reviewn=1,834 · large study2014
In plain English: These issues should be addressed in future trials.
Chen X et al. · PloS one (2014)
Noticeable benefit
← WorseNo effectBetter →
The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95%CI 33.30, 75.92) in favour of the CHM plus RP groups.
Detailed sub-group and sensitivity analyses were conducted.
Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies.
3Chemotherapy-induced nausea and vomiting (CINV)Meta-Analysisn=1,843 · large study2016
In plain English: The oxaliplatin plus TM groups showed significantly reduced CINV (risk ratio 0.65 [0.59, 0.71], I(2) = 28%) compared with oxaliplatin controls, with or without the addition of conventional anti-eme...
Chen MH et al. · Phytotherapy research : PTR (2016)
Large benefit
← WorseNo effectBetter →
The oxaliplatin plus TM groups showed significantly reduced CINV (risk ratio 0.65 [0.59, 0.71], I(2) = 28%) compared with oxaliplatin controls, with or without the addition of conventional anti-emetics.
These plants warrant further clinical research as potential additions to chemotherapy regimens in patients whose CINV is not sufficiently well controlled by conventional therapies.
16Antiaging mechanisms of dietary saponinsSystematic Review2025
In plain English: Future antiaging research on dietary saponins should prioritize high-purity monomers, optimize their bioactive structure, and yield via synthetic biology and nanoencapsulation, followed by clinical validation of efficacy.
Guo C et al. · Journal of agricultural and food chemistry (2025)
Moreover, some antiaging products based on dietary saponins have been developed and utilized as functional foods or nutritional supplements to achieve antiaging in human wellness.
This review systematically reviews antiaging mechanisms of dietary saponins, including their structure-activity relationship, from fundamental research to the development of associated products.
Future antiaging research on dietary saponins should prioritize high-purity monomers, optimize their bioactive structure, and yield via synthetic biology and nanoencapsulation, followed by clinical validation of efficacy.